PureTech Health PTCHF
OTC PTCHF
$1.48 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

PureTech Health (PTCHF) Research & Development (2025)

Updated

PureTech Health's Research & Development came in at -$56.57 million for the quarter ended Dec 31, 2025, compared with -$69.45 million a year earlier.

Analysis

PureTech Health (PTCHF) Research & Development (2025) Analysis & Trends

Going back to the quarter ended Dec 31, 2023, PureTech Health's Research & Development data covers 5 quarters.

  • Going back by year, Research & Development was -$69.45 million in the year ended Dec 31, 2024, -$96.24 million in the year ended Dec 31, 2023, -$152.43 million in the year ended Dec 31, 2022 and -$110.47 million in the year ended Dec 31, 2021.
  • The five-year range for quarterly Research & Development is -$96.24 million (the quarter ended Dec 31, 2023) to -$24.9 million (the quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.34 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.05 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.76 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.81 Bn
10 PureTech Health 35.77 Mn -1.44 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -24.90 Mn
API Access

PureTech Health Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PTCHF&period=max&api_key=YOUR_API_KEY